L-Ascorbic acid 2-phosphate magnesium

CAS No. 113170-55-1

L-Ascorbic acid 2-phosphate magnesium( —— )

Catalog No. M19384 CAS No. 113170-55-1

L-Ascorbic acid 2-phosphate magnesium (2-Phospho-L-ascorbic acid magnesium) is a long-acting vitamin C derivative that can stimulate collagen formation and expression.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 37 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    L-Ascorbic acid 2-phosphate magnesium
  • Note
    Research use only, not for human use.
  • Brief Description
    L-Ascorbic acid 2-phosphate magnesium (2-Phospho-L-ascorbic acid magnesium) is a long-acting vitamin C derivative that can stimulate collagen formation and expression.
  • Description
    L-Ascorbic acid 2-phosphate magnesium (2-Phospho-L-ascorbic acid magnesium) is a long-acting vitamin C derivative that can stimulate collagen formation and expression. L-Ascorbic acid 2-phosphate magnesium (2-Phospho-L-ascorbic acid magnesium) can be used as a culture medium supplement for the osteogenic differentiation of human adipose stem cells (hASCs). L-Ascorbic acid 2-phosphate magnesium (2-Phospho-L-ascorbic acid magnesium) increases alkaline phosphatase (ALP) activity and expression of runx2A in hASCs during the osteogenic differentiation.(In Vitro):L-Ascorbic acid 2-phosphate (0.1-1.5 mM; 2 to 3 weeks with medium exchange every 2 to 3 days) significantly stimulates cell growth, whereas addition of l-Ascorbic acid (Asc) achieves only weak growth stimulation. A combination of Asc-2P and bFGF significantly increases cell growth, but supplementation with EGF and/or insulin does not have any additional effect .L-Ascorbic acid 2-phosphate (50 μM-250 μM) is needed for the effective osteogenic differentiation of human adipose stem cells (hASCs), and higher concentrations of AsA2-P results in increased runx2 expression and ALP activity. The highest proliferation, ALP activity and runx2 expression is achieved with 150 μM AsA2-P and 10 nM dexamethasone (Dex), and 250 μM AsA2-P and 5 nM Dex.
  • In Vitro
    L-Ascorbic acid 2-phosphate (0.1-1.5 mM; 2 to 3 weeks with medium exchange every 2 to 3 days) significantly stimulates cell growth, whereas addition of l-Ascorbic acid (Asc)?achieves only weak growth stimulation. A combination of Asc-2P and bFGF significantly increases cell growth, but supplementation withEGF and/or insulin does not have any additional effect?.L-Ascorbic?acid?2-phosphate (50 μM-250 μM) is needed for the effective osteogenic differentiation of human adipose stem cells (hASCs), and higher concentrations of AsA2-P results in increased runx2 expression and ALP activity. The highest proliferation, ALP activity and runx2 expression is achieved with 150 μM AsA2-P and 10 nM dexamethasone (Dex), and 250 μM AsA2-P and 5 nM Dex. Cell Viability Assay Cell Line: Human?corneal?endothelial?cells?(HCECs)?Concentration:0.1 mM; 0.3 mM; 1.5 mM Incubation Time:2 to 3 weeks with medium exchange every 2 to 3 days Result:Stimulated HCEC cells growth.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phosphatase
  • Recptor
    IC50: alkaline phosphatase (ALP)| collagen formation| runx2A
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    113170-55-1
  • Formula Weight
    292.56
  • Molecular Formula
    C?H?O?P.?/?Mg
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    OC([C@H](O1)[C@H](C[O-])O)=C(OP([O-])([O-])=O)C1=O.[1.5].[Mg+2]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Shima N et al.Invest Ophthalmol Vis Sci. 2011 Nov 7;52(12):8711-7. 2. Kurata S et al.J Biol Chem. 1991 May 25;266(15):9997-10003.
molnova catalog
related products
  • Ertiprotafib

    Ertiprotafib (PTP 112), a selective and potent inhibitor of protein tyrosine phosphate 1B (PTP1B) and IkappaB kinase β (IKK-β), is a novel insulin sensitizer with potential anticancer activity for the study of type 2 diabetes and breast cancer.

  • ML400

    ML400 (CID73050863) is an allosteric inhibitor of LMPTP with an EC50 of 1μM. ML400 displays good cell-based activity and rodent pharmacokinetics.

  • h-NTPDase-IN-4

    h-NTPDase-IN-4 is a pan-inhibitor of NTPDase, which can inhibit h-NTPDase1, 1h-NTPDase2, h-NTPDase3, h-NTPDase8. The IC50 values were 3.58 μM, 10.21 μM, 0.13 μM and 13.57 μM, respectively.